Dr. Kevin Hay is a Clinician Scientist at the Terry Fox Laboratory and Leukemia/Bone Marrow Transplant Program of BC in Vancouver. Dr. Hay received a Master of Science in Immunology at the University of Manitoba (2008), followed by an MD (2011). After completing residency in Internal Medicine (2014) and a clinical fellowship in Haematology (2016) at the University of British Columbia, he was awarded a scholarship through the Clinician Investigator Program of UBC to pursue a postdoctoral fellowship in cellular immunotherapy which he completed at the Fred Hutchinson Cancer Research Center in Seattle Washington under the mentorship of Dr. Cameron Turtle. Dr. Hay’s research focuses on understanding the unique toxicities associated with chimeric antigen receptor T (CAR-T) cells, as well as the development of novel CAR-T cell therapies.
Clinical Scientist and Hematologist, The Leukemia/Bone Marrow Transplant Program of BC, BC Cancer
Professional Experience
Scientist, Terry Fox Laboratory
Assistant Professor, Medicine, University of British Columbia (UBC)
Clinician Scientist, and Hematologist,
The Leukemia/Bone Marrow Transplant Program of BC, BC Cancer
Medical Director, Clinical Cell Therapy, BC Cancer
Medical Director, Conconi Family Immunotherapy Laboratory, BC Cancer
Post-Graduate Training
Postdoctoral Research Fellow, Cellular Immunotherapy (Supervisor: Dr. Cameron Turtle),
Fred Hutchinson Cancer Research Center, 2016 – 2018
Clinical Investigator Program Fellow in Cellular Immunotherapy,
University of British Columbia, 2016 – 2018
Hematology Fellow, University of British Columbia, 2014 – 2014
Internal Medicine Resident, University of British Columbia, 2011 – 2014
Education
MD (Medicine), University of Manitoba, 2007 – 2011
MSc (Immunology), University of Manitoba, 2005 – 2008
BSc (Biology (Honors) and Chemistry), Trinity Western University, 1999 – 2005